Cyclin A1-specific T cell clones selectively lysed Cyclin A1-expressing primary AML blasts showing the potential therapeutic capacity of a Cyclin A1-targeted T cell therapy [11]. This evidence concerns the gene CCNA1 and acute myeloid leukemia.